Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005056648 | SCV001685188 | likely benign | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002427219 | SCV002729518 | likely benign | Hereditary cancer-predisposing syndrome | 2020-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001274351 | SCV001458393 | likely benign | Fumarase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |